EUVIMEDEUVIMED entdecken
Open Access

Programmed Death Ligand 1–Expressing Macrophages and Their Protective Role in the Joint During Arthritis

Megan Kay Wood iD, Abdel Daoud, Monica Vladut Talor, Hannah Maryam Kalinoski, David Matthew Hughes, Camille Marie Jaime, Jody Elizabeth Hooper, Taejoon Won, Daniela Čiháková iD

Arthritis & Rheumatology · 2024

DOI: 10.1002/art.42749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2024. Verfasst von Megan Kay Wood und 8 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Arthritis, Experimental. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, American Heart Association-American Stroke Association, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Arthritis associated with immune checkpoint inhibitor therapies highlights the importance of immune checkpoint expression for joint homeostasis. We investigated the role of programmed death ligand (PD‐L) 1 in the synovium using a collagen‐induced arthritis (CIA) mouse model.

Methods

We blocked PD‐L1 using blocking antibodies during CIA and assessed the arthritis severity by clinical and histologic scoring. PD‐L1 expression and the origin of synovial macrophages were investigated using flow cytometry and parabiosis. We used Cre‐Lox mice to ascertain the protective role of PD‐L1–expressing macrophages in arthritis. The immune profile of human and murine synovial PD‐L1 + macrophages was determined by reverse transcriptase–polymerase chain reaction, flow cytometry, and single‐cell RNA sequencing.

Results

Anti–PD‐L1 antibody treatment during CIA worsened arthritis with increased immune cell infiltration compared with isotype control, supporting the regulatory role of PD‐L1 in the joint. The main cells expressing PD‐L1 in the synovium were macrophages. Using parabiosis, we showed that synovial PD‐L1 + macrophages were both locally proliferating and partially replaced by the circulation. PD‐L1 + macrophages had increased levels of MER proto‐oncogene tyrosine kinase (MerTK) and interleukin (IL)‐10 expression during acute CIA. Genetic depletion of PD‐L1 on macrophages in Lyz cre PD‐L1 fl/fl mice resulted in worsened CIA compared with controls. We found that human PD‐L1 + macrophages in the synovium of healthy individuals and patients with rheumatoid arthritis express MerTK and IL‐10.

Conclusion

PD‐L1 + macrophages with efferocytotic and anti‐inflammatory characteristics protect the synovium from severe arthritis in the CIA mouse model. Tissue‐protective, PD‐L1–expressing macrophages are also present in the human synovium at homeostasis and during rheumatoid arthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidArthritis, ExperimentalHumansAnimalsMiceB7-H1 Antigenc-Mer Tyrosine KinaseSynovial MembraneDisease Models, AnimalMacrophages

Substanzen

B7-H1 Antigenc-Mer Tyrosine Kinase

Autor:innen und Institutionen

  • Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland.
  • Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Johns Hopkins University Whiting School of Engineering, Baltimore, Maryland.
  • Johns Hopkins University School of Medicine, Graduate Program in Immunology, Baltimore, Maryland.
  • Stanford University School of Medicine, Stanford, California.

ORCID-Profile: Megan Kay Wood, Daniela Čiháková

Förderung

  • NIAMS NIH HHS
  • American Heart Association-American Stroke Association
  • NHLBI NIH HHS
  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Wood, M. K., Daoud, A., Talor, M. V., Kalinoski, H. M., Hughes, D. M., Jaime, C. M., Hooper, J. E., Won, T., & Čiháková, D. (2024). Programmed Death Ligand 1–Expressing Macrophages and Their Protective Role in the Joint During Arthritis. Arthritis & Rheumatology. https://doi.org/10.1002/art.42749

Vancouver

Wood MK, Daoud A, Talor MV, Kalinoski HM, Hughes DM, Jaime CM, et al. Programmed Death Ligand 1–Expressing Macrophages and Their Protective Role in the Joint During Arthritis. Arthritis & Rheumatology. 2024. doi:10.1002/art.42749

BibTeX
@article{Wood2024,
  author = {Wood, Megan Kay and Daoud, Abdel and Talor, Monica Vladut and Kalinoski, Hannah Maryam and Hughes, David Matthew and Jaime, Camille Marie and Hooper, Jody Elizabeth and Won, Taejoon and Čiháková, Daniela},
  title = {Programmed Death Ligand 1–Expressing Macrophages and Their Protective Role in the Joint During Arthritis},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  doi = {10.1002/art.42749}
}
Kostenlos starten →